Mitochondrial Medicine for Neurological Disorders.
作者信息
Sahab Uddin Md, Alghamdi Badrah S, Ashraf Ghulam Md
机构信息
Department of Pharmacy, Southeast University, Dhaka, Bangladesh.
Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.
出版信息
Curr Neuropharmacol. 2023;21(5):1024-1025. doi: 10.2174/1570159X2105230320095644.
Abstract
摘要
相似文献
1
Mitochondrial Medicine for Neurological Disorders.
Curr Neuropharmacol. 2023;21(5):1024-1025. doi: 10.2174/1570159X2105230320095644.
2
A "one size fits all" gene therapy for neurological disorders with mitochondrial dysfunction.
Mol Ther. 2024 Jul 3;32(7):2045-2046. doi: 10.1016/j.ymthe.2024.06.012. Epub 2024 Jun 26.
3
Mitochondrial neurological diseases: a clinician's perspective.
Neurol India. 2004 Sep;52(3):305-6.
4
A neurological perspective on mitochondrial disease.
Lancet Neurol. 2010 Aug;9(8):829-40. doi: 10.1016/S1474-4422(10)70116-2.
5
[Diagnostic investigations of mitochondrial diseases with neurological symptoms].
Rev Neurol (Paris). 2007 Feb;163(2):254-63. doi: 10.1016/s0035-3787(07)90400-2.
6
Mitochondrial Disorders of the Nervous System: A Review.
Clin Pediatr (Phila). 2019 Apr;58(4):381-394. doi: 10.1177/0009922818821890. Epub 2019 Jan 4.
7
Mitochondrial medicine and mitochondrion-based therapeutics.
Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1437-8. doi: 10.1016/j.addr.2008.07.001. Epub 2008 Jul 17.
8
Medicine. Mitochondrial replacement, evolution, and the clinic.
Science. 2013 Sep 20;341(6152):1345-6. doi: 10.1126/science.1237146.
9
Mitochondrial Diseases: Hope for the Future.
Cell. 2020 Apr 2;181(1):168-188. doi: 10.1016/j.cell.2020.02.051. Epub 2020 Mar 26.
10
GENETICS. Mitochondrial-nuclear DNA mismatch matters.
Science. 2015 Sep 25;349(6255):1449-50. doi: 10.1126/science.aac5271.
本文引用的文献
1
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
Curr Neuropharmacol. 2023;21(5):1081-1099. doi: 10.2174/1570159X21666230316150559.
2
Pharmacological Progress of Mitophagy Regulation.
Curr Neuropharmacol. 2023;21(5):1026-1041. doi: 10.2174/1570159X21666230314140528.
3
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics.
Curr Neuropharmacol. 2023;21(5):1042-1064. doi: 10.2174/1570159X21666221121095618.
4
Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications.
Curr Neuropharmacol. 2023;21(5):1184-1201. doi: 10.2174/1570159X20666221012122855.
5
Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis.
Curr Neuropharmacol. 2023;21(5):1117-1138. doi: 10.2174/1570159X20666220915092703.
6
The Therapeutic Potential of Mitochondria Transplantation Therapy in Neurodegenerative and Neurovascular Disorders.
Curr Neuropharmacol. 2023;21(5):1100-1116. doi: 10.2174/1570159X05666220908100545.
7
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408.
8
What Happens in TBI? A Wide Talk on Animal Models and Future Perspective.
Curr Neuropharmacol. 2023;21(5):1139-1164. doi: 10.2174/1570159X20666220706094248.
9
The Role of Mitochondria-Targeting miRNAs in Intracerebral Hemorrhage.
Curr Neuropharmacol. 2023;21(5):1065-1080. doi: 10.2174/1570159X20666220507021445.
Zotero 插件